Stella Diagnostics Inc.
SLDX · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -62.2% | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -306.2% | – | – | – |
| Other Income/Exp. Net | -$0 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | -321.5% | – | – | – |
| EPS | -0.002 | -0.001 | -0.001 | -0.001 |
| % Growth | -166.7% | 14.3% | 12.5% | – |
| EPS Diluted | -0.002 | -0.001 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 402 | 402 | 402 | 402 |
| Weighted Avg Shares Out Dil | 402 | 402 | 402 | 402 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | -$0 |
| EBITDA | -$1 | -$0 | -$0 | -$0 |
| % Margin | -306.2% | – | – | – |